We are live on !
Find out more
XTX Topco Portfolio holdings
AUM
$7.72B
Turnover
39.96%
1-Year Est. Return
32.88%
This Fund
S&P 500
This Quarter Est. Return
+14.41%
1 Year Est. Return
+32.88%
3 Year Est. Return
+87.32%
5 Year Est. Return
+53.71%
10 Year Est. Return
–
AUM
$7.72B
AUM Growth
+$1.97B
(+34%)
Cap. Flow
+$1.58B
Cap. Flow % of AUM
Cap. Flow %
20.47%
Top 10 Holdings %
Top 10 Hldgs %
3.84%
Holding
4,912
New
1,139
Increased
1,694
Reduced
1,253
Closed
824
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$41.2M |
| 2 |
Netflix
NFLX
|
+$35.5M |
| 3 |
Intercontinental Exchange
ICE
|
+$29.7M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$29.4M |
| 5 |
PepsiCo
PEP
|
+$28.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$35.4M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$29.9M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$24.6M |
| 4 |
NVIDIA
NVDA
|
+$23.6M |
| 5 |
Arm
ARM
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.1% |
| 2 | Financials | 15.06% |
| 3 | Industrials | 13.66% |
| 4 | Healthcare | 12% |
| 5 | Consumer Discretionary | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1626
Arcutis Biotherapeutics
ARQT
$3.93B
| $1.19M | 0.02% |
45,545
+2,861
| +7% | +$66.7K |
2025 Q1
5 quarters
|
|
1627
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$14.9B
| $1.19M | 0.02% |
+8,415
| New | +$1.16M |
2026 Q2
0 quarters
|
|
1628
MKS Inc
MKSI
$13.3B
| $1.19M | 0.02% |
2,678
-18,278
| -87% | -$5.72M |
2025 Q4
2 quarters
|
|
1629
ICICI Bank
IBN
$108B
| $1.19M | 0.02% |
40,999
-326,285
| -89% | -$8.82M |
2025 Q3
3 quarters
|
|
1630
RPM International
RPM
$13.1B
| $1.19M | 0.02% |
10,685
+445
| +4% | +$46.4K |
2024 Q4
6 quarters
|
|
1631
Janux Therapeutics
JANX
$1.07B
| $1.19M | 0.02% |
77,233
+34,419
| +80% | +$499K |
2025 Q4
2 quarters
|
|
1632
Summit Therapeutics
SMMT
$11.8B
| $1.19M | 0.02% |
+81,402
| New | +$1.44M |
2026 Q2
0 quarters
|
|
1633
C3.ai
AI
$1.86B
| $1.18M | 0.02% |
130,335
+104,135
| +397% | +$989K |
2025 Q3
3 quarters
|
|
1634
DELISTED
Taylor Morrison
TMHC
| $1.18M | 0.02% |
16,507
-1,026
| -6% | -$65.2K |
2024 Q3
7 quarters
|
|
1635
ADMA Biologics
ADMA
$2.48B
| $1.18M | 0.02% |
141,309
-411,484
| -74% | -$3.75M |
2026 Q1
1 quarter
|
|
1636
FormFactor
FORM
$6.82B
| $1.18M | 0.02% |
+7,387
| New | +$980K |
2026 Q2
0 quarters
|
|
1637
Silence Therapeutics
SLN
$1.23B
| $1.18M | 0.02% |
107,579
+1,577
| +1% | +$11.1K |
2025 Q4
2 quarters
|
|
1638
iShares Core Dividend ETF
DIVB
$2.3B
| $1.18M | 0.02% |
+19,156
| New | +$1.12M |
2026 Q2
0 quarters
|
|
1639
Kimball Electronics
KE
$620M
| $1.18M | 0.02% |
46,084
+33,407
| +264% | +$858K |
2025 Q3
3 quarters
|
|
1640
Tecnoglass Holdings
TGLS
$1.71B
| $1.18M | 0.02% |
25,199
-9,069
| -26% | -$392K |
2025 Q4
2 quarters
|
|
1641
Assembly Biosciences
ASMB
$410M
| $1.18M | 0.02% |
42,918
+32,133
| +298% | +$875K |
2026 Q1
1 quarter
|
|
1642
Direxion Daily MU Bull 2X ETF
MUU
$2.66B
| $1.18M | 0.02% |
22,460
-270,740
| -92% | -$7.69M |
2026 Q1
1 quarter
|
|
|
ACA
1643
DELISTED
Arcosa
ACA
| $1.18M | 0.02% |
8,100
-5,842
| -42% | -$726K |
2026 Q1
1 quarter
|
|
1644
Wipro
WIT
$21.4B
| $1.18M | 0.02% |
522,772
+215,996
| +70% | +$459K |
2025 Q2
4 quarters
|
|
1645
DELISTED
ACV Auctions
ACVA
| $1.18M | 0.02% |
163,571
-268,958
| -62% | -$1.52M |
2025 Q3
3 quarters
|
|
1646
Liberty Latin America Class C
LILAK
$1.64B
| $1.18M | 0.02% |
150,964
+103,058
| +215% | +$747K |
2026 Q1
1 quarter
|
|
1647
Vanguard Tax-Exempt Bond Index Fund
VTEB
$51.2B
| $1.18M | 0.02% |
23,232
+681
| +3% | +$34.2K |
2025 Q4
2 quarters
|
|
1648
Sturm, Ruger & Co
RGR
$706M
| $1.17M | 0.02% |
30,937
+8,112
| +36% | +$326K |
2026 Q1
1 quarter
|
|
1649
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$189M
| $1.17M | 0.02% |
+31,585
| New | +$1.2M |
2026 Q2
0 quarters
|
|
1650
First Interstate BancSystem
FIBK
$3.62B
| $1.17M | 0.02% |
30,337
-2,650
| -8% | -$93.8K |
2025 Q4
2 quarters
|
|
Similar funds
XTX Topco's Q2 2026 Portfolio in Review
As of Q2 2026, XTX Topco held 4,912 positions worth $7.72B, up 34% from $5.75B the previous quarter. Its ten largest holdings account for 3.8% of the portfolio.
XTX Topco deployed $1.58B of net new capital in Q2 2026, opening 1,139 new positions and adding to 1,694 existing holdings. Its largest new stake was Netflix: 403,127 shares worth $28.8M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $29.9M trimmed.
- XTX Topco's largest Q2 2026 buy was Netflix: 403,127 shares worth $28.8M.
- XTX Topco added most to Chevron in Q2 2026, an estimated $41.2M increase.
- XTX Topco's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $29.9M.
- XTX Topco fully exited iShares MSCI South Korea ETF in Q2 2026, selling an estimated $35.4M.
- XTX Topco's ten largest holdings make up 3.8% of its $7.72B portfolio in Q2 2026.
- XTX Topco opened 1,139 new positions and closed 824 in Q2 2026.
- XTX Topco's portfolio value rose 34% quarter-over-quarter to $7.72B.
Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.